← SynDRA
ULOTARONT
SynDRA canonical compound SYN0040166 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR1A | TAAR1 |
|---|
| Mechanism of action | trace amine associated receptor agonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- HTR1A AGONIST
- Serotonin 1a (5-HT1a) receptor agonist
- TAAR1 AGONIST
- Trace amine-associated receptor 1 agonist
- trace amine associated receptor agonist
Cross-references
Synonyms
- SEP-363856
- SEP-856
- SEP 363856
- 3K6270MG59
- RefChem:182411
- methyl((((7S)-4H,5H,7H-thieno(2,3-c)pyran-7-yl)methyl))amine
- UNII-3K6270MG59
- SEP363856
- ulotarontum
- UJL
- ULOTARONT [INN]
- Ulotaront (USAN/INN)
- ULOTARONT [USAN]
- orb1708533
- SCHEMBL14903737
- GTPL10454
- CHEBI:228346
- SEP-363856 (parent molecule)
- BDBM50581604
- AKOS040738084
- HY-136109A
- DA-57800
- Ulotaront; SEP-363856 ; SEP-856
- example 129 [WO2011069063A2]
- CS-0119593
- D12474
- T12899
- Улотаронт
- T12899L
- DA-57801
- Ulotaront hydrochloride (JAN/USAN)
- 6P8Y2467AU
- UNII-6P8Y2467AU
- SEP-363856 HYDROCHLORIDE
- SEP-363856 HCl
- SCHEMBL21273308
- SEP-363856 hydrochloride
- F96104
- CS-0119592
Look up ULOTARONT in the interactive SynDRA portal →